Aug 24, 2026 06:55AM
Aug 24, 2026 06:55AM
Aug 7, 2026 06:50AM
Jul 16, 2026 04:36PM
Jul 16, 2026 04:34PM
Jul 13, 2026 06:50AM
Jul 13, 2026 06:50AM ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chroni
May 8, 2026 06:50AM
Apr 20, 2026 06:50AM
Apr 20, 2026 06:50AM
Apr 13, 2026 06:53AM
Apr 13, 2026 06:50AM
Apr 8, 2026 06:50AM
Apr 8, 2026 06:50AM ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
Apr 7, 2026 08:44AM
Apr 7, 2026 06:50AM
Apr 7, 2026 06:50AM
Apr 7, 2026 06:50AM
Feb 27, 2026 06:50AM
Jan 12, 2026 06:50AM
Jan 12, 2026 06:50AM ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
Dec 2, 2025 06:50AM
Dec 2, 2025 06:50AM
Dec 1, 2025 06:50AM
Dec 1, 2025 06:50AM
Nov 7, 2025 06:50AM
Oct 16, 2025 06:50AM
Oct 16, 2025 06:50AM ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting
Sep 8, 2025 07:23AM
Aug 8, 2025 06:50AM
Jul 29, 2025 04:09PM
Jul 29, 2025 04:05PM
Jul 23, 2025 06:51AM
Jul 23, 2025 06:50AM
Jun 12, 2025 07:00AM ANI Pharmaceuticals Announces Presentation of New Preclinical Data
May 22, 2025 06:50AM
May 9, 2025 06:50AM
May 5, 2025 07:00AM
Mar 19, 2025 06:50AM
Mar 19, 2025 06:50AM
Mar 18, 2025 06:50AM
Mar 18, 2025 06:50AM ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®
Mar 14, 2025 06:52AM
Mar 14, 2025 06:50AM
Mar 3, 2025 04:30PM
Mar 3, 2025 04:30PM
Feb 28, 2025 06:50AM
Feb 28, 2025 06:50AM
Jan 13, 2025 06:52AM ANI Pharma (ANIP) Reports Prelim Q4, 2025 Outlook
Jan 13, 2025 06:50AM

329,911 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All